What is Cellivate Technologies?
Cellivate Technologies is at the forefront of developing innovative animal-free solutions for cell growth, catering to critical industries such as pharmaceuticals, skincare, and food production. Their flagship product, Booster, offers a compelling ethical alternative to Fetal Bovine Serum, enhancing cell growth for applications in drug development and regenerative medicine. The company's commitment to sustainability and consistent quality positions it as a key enabler for businesses transitioning to cruelty-free practices, leveraging cutting-edge technology to deliver reliable, high-performance solutions that meet stringent environmental standards.
How much funding has Cellivate Technologies raised?
Cellivate Technologies has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2024): $1M with participation from Antler, We Founder Circle, Hatcher, and Venture Catalysts Uttar Pradesh
Key Investors in Cellivate Technologies
Antler
Antler is a global venture capital firm that partners with exceptional founders across continents to launch and scale startups, focusing on building a better future through innovation.
We Founder Circle
We Founder Circle is an Indian startup investor community that provides seed funding and business development support to early-stage startups, driven by a founder-first investment thesis.
Hatcher
Hatcher+ utilizes an AI-driven platform, FAAST, to help investors create more effective portfolios, focusing on technology-enhanced investment strategies.
What's next for Cellivate Technologies?
With this substantial enterprise-level investment, Cellivate Technologies is poised for accelerated expansion and product development. The strategic capital injection is expected to bolster research initiatives, scale manufacturing capabilities, and broaden market reach, particularly in the pharmaceutical and biotechnology sectors where the demand for ethical and consistent cell culture media is rapidly increasing. This funding round signifies a pivotal moment, enabling Cellivate to solidify its position as a leader in sustainable life science solutions and drive further innovation in cruelty-free biotechnology.
See full Cellivate Technologies company page
